[Supplementary enzyme treatment of urinary tract infections].
Naber
K
K
Wissenschaftlichen Gesellschaft zur Förderung der Enzymforschung und berät die Firma Mucos Pharma GmbH & Co KG bei wissenschaftlichen Fragestellungen. kurt@nabers.de
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D057487:Enzyme Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D014552:Urinary Tract Infections / Q000188:drug therapy*; D055815:Young Adult
D000890:Anti-Infective Agents